Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

NCT03617913 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall
Stage II Bladder Cancer AJCC v8
Stage II Renal Pelvis Cancer AJCC v8
Stage II Ureter Cancer AJCC v8
Stage II Urethral Cancer AJCC v8
Stage III Bladder Cancer AJCC v8
Stage III Renal Pelvis Cancer AJCC v8
Stage III Ureter Cancer AJCC v8
Stage III Urethral Cancer AJCC v8
Stage IIIA Bladder Cancer AJCC v8
Stage IIIB Bladder Cancer AJCC v8
Urethral Urothelial Carcinoma

Interventions

DRUG: Avelumab
DRUG: Cisplatin
DRUG: Fluorouracil
DRUG: Mitomycin
OTHER: Quality-of-Life Assessment
RADIATION: Radiation Therapy

Sponsor

Mayo Clinic

Collaborators

[object Object]